Management of Symptoms in Children With Autism Spectrum Disorders: A Comprehensive Review of Pharmacologic and Complementary-Alternative Medicine Treatments

被引:55
作者
Huffman, Lynne C. [1 ]
Sutcliffe, Trenna L. [2 ]
Tanner, Ima S. D. [3 ]
Feldman, Heidi M. [1 ]
机构
[1] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA
[2] Palo Alto Med Fdn, Dept Pediat, Los Altos, CA USA
[3] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA
关键词
autism; autism spectrum disorder; review; treatment; pharmacologic; complementary-alternative medicine; PERVASIVE DEVELOPMENTAL DISORDERS; PLACEBO-CONTROLLED CROSSOVER; SYNTHETIC HUMAN SECRETIN; LONG-TERM RISPERIDONE; OPEN-LABEL TRIAL; DOUBLE-BLIND; PORCINE SECRETIN; YOUNG-CHILDREN; RETROSPECTIVE ASSESSMENT; NALTREXONE TREATMENT;
D O I
10.1097/DBP.0b013e3182040acf
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
In the care of children with autism spectrum disorders (ASD), medical treatment is typically considered an adjunct to educational and behavioral interventions. Nonetheless, large proportions of children with ASD are managed medically and receive both pharmacologic and complementary-alternative medicine (CAM) treatments. Although many medical treatments have been studied in children with ASD, studies vary widely in terms of the sample, sample size, research design, purposes of treatment, and measurements of change. Surprisingly, comprehensive reviews of the options for medical management in ASD are lacking, particularly reviews that address both pharmacologic and CAM treatments. Furthermore, reviews to date tend to emphasize general effects of medication; this perspective contradicts medical practice, which targets particular symptoms during treatment selection and monitoring. This review of 115 studies adds to the ASD treatment literature by (1) including studies of individuals 0 to 22 years of age; (2) aggregating studies of pharmacologic treatments and CAM treatments; and importantly, (3) organizing treatment response by ASD symptoms, differentiating core and associated symptoms.
引用
收藏
页码:56 / 68
页数:13
相关论文
共 136 条
[81]   A 3-year naturalistic study of 53 preschool children with pervasive developmental disorders treated with risperidone [J].
Masi, G ;
Cosenza, A ;
Mucci, M ;
Brovedani, P .
JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (09) :1039-1047
[82]   Risperidone in children with autism and serious behavioral problems [J].
McCracken, JT ;
McGough, J ;
Shah, B ;
Cronin, P ;
Hong, D ;
Aman, MG ;
Arnold, E ;
Lindsay, R ;
Nash, P ;
Hollway, J ;
McDougle, CJ ;
Posey, D ;
Swiezy, N ;
Kohn, A ;
Scahill, L ;
Martin, A ;
Koenig, K ;
Volkmar, F ;
Carroll, D ;
Lancor, A ;
Tierney, E ;
Ghuman, J ;
Gonzalez, NM ;
Grados, M ;
Vitiello, B ;
Ritz, L ;
Davies, M ;
Robinson, J ;
McMahon, D .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (05) :314-321
[83]  
Mccracken JT, 2005, AM J PSYCHIAT, V162, P1361
[84]   Risperidone for the core symptom domains of autism: Results from the study by the autism network of the research units on pediatric psychopharmacology [J].
McDougle, CJ ;
Hollway, J ;
Scahill, L ;
Koenig, K ;
Aman, MG ;
McGough, JJ ;
McCracken, JT ;
Ritz, L ;
Tierney, E ;
Vitiello, B ;
Davies, M ;
Arnold, LE ;
Posey, DJ ;
Martin, A ;
Ghuman, JK ;
Shah, B ;
Chuang, SZ ;
Swiezy, NB ;
Gonzalez, NM .
AMERICAN JOURNAL OF PSYCHIATRY, 2005, 162 (06) :1142-1148
[85]   Case series: Use of ziprasidone for maladaptive symptoms in youths with autism [J].
McDougle, CJ ;
Kem, DL ;
Posey, DJ .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2002, 41 (08) :921-927
[86]   Risperidone treatment of children and adolescents with pervasive developmental disorders: A prospective, open-label study [J].
McDougle, CJ ;
Holmes, JP ;
Bronson, MR ;
Anderson, GM ;
Volkmar, FR ;
Price, LH ;
Cohen, DJ .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1997, 36 (05) :685-693
[87]   Lack of benefit of intravenous synthetic human secretin in the treatment of autism [J].
Molloy, CA ;
Manning-Courtney, P ;
Swayne, S ;
Bean, J ;
Brown, JM ;
Murray, DS ;
Kinsman, AM ;
Brasington, M ;
Ulrich, CD .
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 2002, 32 (06) :545-551
[88]  
Mousain-Bosc M, 2006, MAGNESIUM RES, V19, P53
[89]   Short-term efficacy and safety of risperidone in young children with autistic disorder (AD) [J].
Mukaddes, NM ;
Abali, O ;
Gurkan, K .
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2004, 5 (04) :211-214
[90]   Management of children with autism spectrum disorders [J].
Myers, Scott M. ;
Johnson, Chris Plauche .
PEDIATRICS, 2007, 120 (05) :1162-1182